• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Finding potential DNA-binding compounds by using molecular shape.

作者信息

Grootenhuis P D, Roe D C, Kollman P A, Kuntz I D

机构信息

Department of Pharmaceutical Chemistry, University of California, San Francisco 94143-0446, USA.

出版信息

J Comput Aided Mol Des. 1994 Dec;8(6):731-50. doi: 10.1007/BF00124018.

DOI:10.1007/BF00124018
PMID:7738607
Abstract

For the first time a general shape-search docking algorithm (DOCK) has been applied to the minor and major grooves of A-, B- and Z-type DNA dodecamers and to an intercalation site in a B-DNA-type hexamer. Both experimentally and theoretically derived geometries for the various DNA fragments were used. The DOCK searches were carried out on a subset of the Cambridge Crystallographic Database, consisting of almost 10,000 molecules. One of the molecules that scored best in terms of the DOCK algorithm was CC-1065, a potent antitumor agent known to (covalently) bind the AT-rich parts of the minor groove of B-DNA. Several known DNA-binding agents also scored highly. Molecules with shapes complementary to A-, B- and Z-type DNA were indicated by DOCK. In addition, compounds were extracted from the database that might be selective for the GC-rich regions of the minor groove of B-DNA. Many of the compounds in the present study may serve as a starting point for further molecular design of novel DNA-binding ligands.

摘要

相似文献

1
Finding potential DNA-binding compounds by using molecular shape.
J Comput Aided Mol Des. 1994 Dec;8(6):731-50. doi: 10.1007/BF00124018.
2
Solution structure of the esperamicin A1-DNA complex.埃斯帕霉素A1-DNA复合物的溶液结构
J Mol Biol. 1997 Jan 17;265(2):173-86. doi: 10.1006/jmbi.1996.0719.
3
Major versus minor groove DNA binding of a bisarginylporphyrin hybrid molecule: a molecular mechanics investigation.双精氨酰卟啉杂合分子与DNA大沟和小沟的结合:分子力学研究
J Comput Aided Mol Des. 1999 Mar;13(2):123-37. doi: 10.1023/a:1008033219724.
4
Heterogeneity in the actions of drugs that bind in the DNA minor groove.结合于DNA小沟的药物作用的异质性。
Biochemistry. 1999 Aug 3;38(31):10135-46. doi: 10.1021/bi990382p.
5
Solution structure of mithramycin dimers bound to partially overlapping sites on DNA.与DNA上部分重叠位点结合的光神霉素二聚体的溶液结构。
J Mol Biol. 1995 Sep 1;251(5):674-89. doi: 10.1006/jmbi.1995.0464.
6
Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).糖苷配基修饰对蒽环类药物与DNA结合的影响:伊达比星和4-O-去甲基-11-脱氧多柔比星与d(CGATCG)复合的分子结构
Anticancer Drug Des. 1991 Jul;6(3):137-49.
7
A novel form of intercalation involving four DNA duplexes in an acridine-4-carboxamide complex of d(CGTACG)(2).一种涉及 d(CGTACG)(2) 的吖啶 - 4 - 甲酰胺复合物中四条 DNA 双链体的新型嵌入形式。
Nucleic Acids Res. 2000 Nov 1;28(21):4244-53. doi: 10.1093/nar/28.21.4244.
8
Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.DNA双链中与dC相对的(-)-顺式-反式苯并[a]芘基-dG加合物的溶液构象:共价连接的BP环插入螺旋,修饰的脱氧鸟苷碱基位移至大沟。
Biochemistry. 1996 Jul 30;35(30):9850-63. doi: 10.1021/bi9605346.
9
Theoretical studies of the intercalation of 9-hydroxyellipticine in DNA.9-羟基玫瑰树碱嵌入DNA的理论研究。
Biopolymers. 1996 Sep;39(3):309-26. doi: 10.1002/(SICI)1097-0282(199609)39:3%3C309::AID-BIP4%3E3.0.CO;2-S.
10
Molecular modeling to study DNA intercalation by anti-tumor drugs.
Methods Enzymol. 1991;203:433-58. doi: 10.1016/0076-6879(91)03024-b.

引用本文的文献

1
A Discovery Funnel for Nucleic Acid Binding Drug Candidates.用于核酸结合候选药物的发现漏斗。
Drug Dev Res. 2011 Mar 1;72(2):178-186. doi: 10.1002/ddr.20414.
2
Molecular docking of intercalators and groove-binders to nucleic acids using Autodock and Surflex.使用自动对接(Autodock)和表面柔性对接(Surflex)技术将嵌入剂和沟槽结合剂与核酸进行分子对接。
J Chem Inf Model. 2008 Aug;48(8):1602-15. doi: 10.1021/ci800063v. Epub 2008 Jul 22.
3
Similarity and complementarity of molecular shapes: applicability of a topological analysis approach.

本文引用的文献

1
A geometric approach to macromolecule-ligand interactions.一种研究大分子-配体相互作用的几何方法。
J Mol Biol. 1982 Oct 25;161(2):269-88. doi: 10.1016/0022-2836(82)90153-x.
2
Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).一种抗癌药物 - DNA 复合物的分子结构:柔红霉素加 d(CpGpTpApCpG)
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7204-8. doi: 10.1073/pnas.77.12.7204.
3
Solvent-accessible surfaces of proteins and nucleic acids.蛋白质和核酸的溶剂可及表面。
分子形状的相似性与互补性:拓扑分析方法的适用性
J Comput Aided Mol Des. 1996 Feb;10(1):55-66. doi: 10.1007/BF00124465.
Science. 1983 Aug 19;221(4612):709-13. doi: 10.1126/science.6879170.
4
Physical association of oestrogens and other steroids with DNA.雌激素和其他类固醇与DNA的物理关联。
Biochem Pharmacol. 1983 Sep 1;32(17):2571-5. doi: 10.1016/0006-2952(83)90020-5.
5
Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity.
Science. 1984 Nov 16;226(4676):843-4. doi: 10.1126/science.6494915.
6
Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex.CC-1065与特定寡脱氧核苷酸双链体之间加合物的表征
Nucleic Acids Res. 1984 Aug 10;12(15):6159-68. doi: 10.1093/nar/12.15.6159.
7
Structural and sequence-dependent aspects of drug intercalation into nucleic acids.药物嵌入核酸的结构和序列依赖性方面。
CRC Crit Rev Biochem. 1984;17(1):73-121. doi: 10.3109/10409238409110270.
8
On the possible mechanism of recognition of DNA base sequence by steroid hormones.关于甾体激素识别DNA碱基序列的可能机制。
FEBS Lett. 1987 Dec 10;225(1-2):151-8. doi: 10.1016/0014-5793(87)81148-1.
9
Molecular basis for sequence-specific DNA alkylation by CC-1065.CC-1065对序列特异性DNA烷基化的分子基础。
Biochemistry. 1988 May 17;27(10):3886-92. doi: 10.1021/bi00410a054.
10
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.利用形状互补性作为初步筛选方法,来设计针对已知三维结构受体结合位点的配体。
J Med Chem. 1988 Apr;31(4):722-9. doi: 10.1021/jm00399a006.